Back to results
US 11,512,302 B2Granted
Modifications to lysine decarboxylase enzymes
AssigneesCathay Biotech Inc., Cibt America Inc.
InventorsHoward Chou, Wenqiang Lu, Ling Chen, Lijun Yu, Xiucai Liu
Life of this patent
Estimating the term…
Abstract
The invention provides CadA polypeptides with mutations that increase activity in alkaline pH compared to the wild-type lysine decarboxylase. The invention also provides methods of generating such mutant polypeptides, microorganisms genetically modified to overexpress the mutant polypeptides, and methods of generating such microorganism.
Claims17
A CadA variant polypeptide comprising at least one amino acid substitution at a lysine residue in a region corresponding to amino acids 276 to 509 as determined with reference to SEQ ID NO:
- 2, wherein the lysine residue occurs at the surface of the CadA variant polypeptide with the side chain oriented towards the external environment in a segment of the CadA variant polypeptide that lacks a defined secondary structure;
- and wherein the CadA variant polypeptide has at least 99% identity to any one of SEQ ID NOs:
- 2 to 5, wherein the substitution is at least at one of positions K320 and K325, wherein the substitution at position K320 is K320A/C/E/G/H/I/L/M/S/V/Y, and wherein the substitution at position K325 is K325C, wherein the lysine decarboxylase activity of the CadA variant polypeptide is improved compared to that of a wildtype CadA of one of SEQ ID NOs:
- 2 to 5.
1 more element
Dependencies are inferred from the claim text.